Business
Currency:USD
2025/Q1
Stock NameRevenueRatio
Sterilization and Disinfection Control22.96M39.47%
Biopharmaceutical Development12.01M20.64%
Calibration Solutions11.8M20.29%
Clinical Genomics11.4M19.60%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States106.4M49.21%
Other84.86M39.25%
People's Republic of China24.93M11.53%
